The Excell-ence Exclusive: Advancing Cell Therapy Innovations | May 2025
Welcome back to The Excell-ence Exclusive! Your quarterly source for expert insights into cell therapy manufacturing. In each issue, we share thought-provoking articles from the Excellos scientific team, highlighting technical expertise, industry trends, and best practices to help you accelerate your projects and stay ahead in the fast-moving world of cell therapy. Contact us for […]
Starting Strong: Why Your Cell Therapy Begins with the Right Material
When it comes to cell therapy, your starting material can make all the difference — not just in outcomes, but in efficiency, reproducibility, and long-term success. At Excellos, we believe the quality and consistency of your donor material should never be an afterthought. Through our deep partnership with San Diego Blood Bank, we offer more […]
Proud to Be Part of ARM: Advancing the Future of Regenerative Medicine Together
Proud to Be Part of ARM: Advancing the Future of Regenerative Medicine Together At Excellos, we are honored to be a member of the Alliance for Regenerative Medicine—a driving force behind the progress, innovation, and advocacy that is transforming the field of regenerative medicine. Alliance for Regenerative Medicine also known as ARM As a member […]
Spotlight on Excell-ence: Quality Assurance Team
Spotlight on Excellence: Cell Therapy Quality Assurance Team The value of a QA team at a cell therapy CDMO lies in their ability to ensure that every aspect of the development and manufacturing process is performed with the highest level of quality, safety, and regulatory compliance. Their role ensures that the products manufactured are safe, […]
Excellos Launches Cell Therapy Manufacturing Newsletter: Innovation Updates in CAR-T and GMP Production
Find how you can see state-of-the-art manufacturing, why decentralized manufacturing makes sense, and why mito functions are key to selecting CAR-T donors. Excellos Newsletter Launches Focusing on Innovations in Cell Therapy Manufacturing Find how you can see state-of-the-art manufacturing, why decentralized manufacturing makes sense, and why mito functions are key to selecting CAR-T donors. Welcome […]
Spotlight on Excell-ence: Project Management Team
Excellos project management team At Excellos, our success is built on the expertise and dedication of our incredible teams. In this ongoing series, we’re highlighting the people behind the innovation—showcasing the teams that make our work possible. First up, our Project Management Team: the experts ensuring seamless execution and unparalleled customer support. Meet Erin Darnley, […]
Excellos & SDBB: A Legacy of Innovation and Impact
Excellos: From Blood Bank Division to Leading Cell Therapy CDMO | A Legacy of Innovation At Excellos, we are driven by a mission that seamlessly blends cutting-edge science with a legacy of service. Our journey began as a division of the San Diego Blood Bank (SDBB), a nonprofit with over 70 years of experience in […]
Excellos Ensures Reliability and Patient Safety with XiltriX
This case study is available as a downloadable PDF for offline reading.
Choosing the right PBMCs for your research and product development needs
What you need to know about choosing peripheral blood mononuclear cells for your research and development projects What are PBMCs? Human peripheral blood mononuclear cells (PBMCs) are key components of the body’s immune system. PBMCs are typically isolated from whole blood by apheresis and used for a variety of downstream applications, such as feeder […]
Allogeneic Cell Therapy Advances at AACR 2024
American Association for Cancer Research (AACR) held their 2024 annual meeting in San Diego CA. This conference served as a platform for groundbreaking advancements in allogeneic cell therapy highlighted across a range of diseases. Safeguarding allogeneic cell therapy products Among the noteworthy developments were discoveries from Century Therapeutics whose presentation of preclinical data revealed […]